Part of Oral Answers to Questions — Prime Minister – in the House of Commons at on 15 May 2019.
My hon. Friend raised a very important issue at the time, and I am very pleased that NHS England and Biogen have agreed a deal that enables NICE to recommend this revolutionary new treatment. As he said, it has the potential to transform the lives of young children with spinal muscular atrophy and their families, and I will certainly ensure that the Department of Health and Social Care acts on his request that it be made available as quickly as possible.